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In the last twenty years, the general view of the plasma membrane has changed from a homogeneous arrangement of lipids to a
mosaic of microdomains.It is currently thought that islands of highly ordered saturated lipids and cholesterol, which are laterally
mobile, exist in the plane of the plasma membrane. Lipid rafts are thought to provide a means to explain the spatial segregation
of certain signalling pathways emanating from the cell surface. They seem to provide the necessary microenvironment in order
for certain specialised signalling events to take place, such as the innate immune recognition. The innate immune system seems
to employ germ-lined encoded receptors, called pattern recognition receptors (PRRs), in order to detect pathogens. One family
of such receptors are the Toll-like receptors (TLRs), which are the central “sensing” apparatus of the innate immune system. In
recent years,ithasbecome apparentthatTLRsarerecruited intomembranemicrodomainsinresponseto ligands.Thesenanoscale
assembliesofsphingolipid,cholesterol,andTLRs stabilizeandcoalesce,formingsignallingplatforms,whichtransduce signalsthat
lead to innate immune activation. In the current paper, we will investigate all past and current literature concerning recruitment
of extracellular and intracellular TLRs into lipid rafts and how this membrane organization modulates innate immune responses.
1.Introduction
The general view of the cellular plasma membrane has
evolved over the last twenty years from that of a homo-
geneous arrangement of lipids with embedded proteins
towards that of a mosaic of microdomains, each having a
speciﬁc protein and lipid composition [1]. Over the last
couple of decades, evidence has accumulated for organisa-
tionoftheplasma membraneintolipid-basedmicrodomains
or lipid rafts. A new model of membrane architecture has
been suggested [2] in which the membrane is patchy with
segregated cholesterol-rich portions, called lipid rafts. Lipid
rafts are envisaged as islands of highly ordered saturated
lipids and cholesterol that are laterally mobile in the plane
of a more ﬂuid disordered bilayer of largely unsaturated
lipids [3, 4]. The hallmark of the lipid raft hypothesis
are the spontaneous partitioning of lipids and proteins in
discrete membrane domains, a behaviour based on their
physicochemical characteristics and the possibility to recover
these microdomains and their associated protein machinery
as detergent-resistant entities using biochemical ﬂotation
experiments. Microdomains appear as small dynamic struc-
tures that can aggregate into larger platforms in response to
various stimuli [5].
Currently, lipid rafts are thought to allow diﬀerent
protein-lipid and protein-protein interactions that tem-
porarily compartmentalise the plasma membrane. Lipid
rafts are thought to provide a means to explain the spatial
segregation of certain signalling pathways emanating from
thecell surface. Theyseemtoprovidethe necessary microen-
vironment in order for certain specialised signalling events
to take place. Recent studies have shown the importance2 Mediators of Inﬂammation
of lipid raft formation in the acquired immune response.
Major Histocompatibility Complex- (MHC-) restricted T-
cell activation seems to be facilitated by lipid raft formation
[6]. Furthermore, we have recently found that mediators
of the innate immune response also concentrate in lipid
rafts in order to facilitate signal transduction [7, 8], thus
suggesting that both the acquired and innate immune
systems utilisemembrane partitioningas means ofactivation
against invadingpathogens.Crucialreceptorsforbothinnate
and acquired immunity seem to oligomerize in nonrandom
membrane structures, bringing together their signalling
machinery. Thus accumulation of receptors within these
“ﬂoating islands” on the cell membrane seems to bring
together intracellularly all the adaptor molecules that are
necessary for signalling. In this paper, we will investigate
further the mechanisms of innate immune recognition and
review past and current literature that leads us to believe that
membrane partitioning and lipid rafts play a central role in
innate immune activation.
2.The Innate Immune System
The innate immune system constitutes the most archaic part
of our immune defences and has survived through years
of evolution. Its function is thought to be the recognition
of invading pathogens, the activation of inﬂammation to
c o n t r o lt h ep a t h o g e n ,a n dt h es u b s e q u e n ta c t i v a t i o no f
the acquired immune response. As part of its mechanism
of activation, the innate immune system employs germ-
lined encoded receptors, called pattern recognition receptors
(PRRs) in order to “sense” pathogens. These PRRs recognise
a restricted collection of microbial signatures, able to sense
diﬀerent types of microbial pathogens ranging from bacteria
and viruses to fungi and spirochetes. Lipid rafts seem to be a
key feature of the innate immune response, playing a crucial
role in phagocytosis, receptor-receptor as well as receptor-
pathogenassociations aswell as signal transduction.Families
of PRRs, such as the Toll-like receptor family (TLR) as well
as the C-type lectin family seem to localise in lipid rafts
for their function thus demonstrating the importance of
this membrane partitioning for the function of the innate
immune response.
2.1. The Toll-Like Receptor Family. The TLR receptor family
were the ﬁrst pattern recognition receptors to be identiﬁed
[9, 10]. This family of at least ten germ-line encoded recep-
tors is able to“sense” microbial signatures and trigger activa-
tionleadingtoproinﬂammatory cytokinesecretion.TLRsare
expressed on immune cells and are able to distinguish a great
variety of microbial ligands, such as cell wall components
like lipopolysaccharide (LPS) from Gram-negative bacteria
and lipoteichoic acid from Gram-positive bacteria, bacterial
ﬂagellin, CpG DNA, and viral DNA or single stranded RNA
[11].
All identiﬁed TLRs are type I transmembrane proteins,
whose intracellular domains contain regions homologous
to the intracellular domains of IL-1R and are referred to as
TIR domains [11]. These intracellular domains are able to
trigger signalling pathways known to activate the nuclear
factor kappa B (NF-κB) [12, 13], which in turn leads to the
secretion ofproinﬂammatory cytokines such as TNF-α,I L - 6 ,
and IL-8.
TLR4 was found to recognise bacterial lipopolysaccha-
ride (LPS) or endotoxin [14, 15]; TLR2 was found to
recognise lipoteichoic acid (LTA) and peptidoglycan [16];
TLR3 was able to sense double-stranded viral RNA [17];
TLR5 was found to recognise bacterial ﬂagellin [18], TLR7
[19]a n dT L R 8[ 20] to sense single stranded viral RNA,
whereas TLR9 to recognise bacterial CpG DNA [21]. In
addition, TLR2 was found to recognise diﬀerent motifs
including several components of Gram-positive bacteria
such as peptidoglycan [22], lipoteichoic acid (LTA) [23],
lipoarabinomannan [24], lipoproteins [25], and diﬀerent
LPS from certain Gram-negative bacteria [26], yeast [27],
spirochete, and fungi [28, 29] through its unique ability
to heterodimerize with TLRs 1 and 6 [30]. Studies using
diacylated and triacylated lipoproteins have revealed that
diacylated lipoproteins require TLR2/6 heterodimers for
activation, whereas triacylated lipoproteins induceactivation
of the innate immune system independently of TLR6 and
mainly through TLR2/TLR1 heterodimers [25, 31–35].
ThemembranedistributionofTLRsaswellastheirintra-
cellular traﬃcking has only now begun to be investigated.
Most TLRs (TLR1, TLR2, TLR4, TLR5, and TLR6) seem to
activate cells by engaging their ligands on the cell surface,
whereas TLR3, TLR7, TLR8, and TLR9 seem to trigger
signalling intracellularly. These TLRs have been shown to
reside in the ER and to recognise their ligands once theyhave
been endocytosed [36, 37].
2.2. Innate Immune Recognition of Bacterial Endotoxin or
Lipopolysaccharide. Investigations into the innate immune
recognition of bacterial endotoxin led to the discovery of the
TLR family. TLR4 is the most studied TLR, mainly because
of its involvement with sepsis and septic shock. Sepsis is
a paradoxical and complex disorder that results from an
overreaction of our innate immune system to bacterial
infections. The mechanisms that are designed to protect
the host against infection by bacterial pathogens, either
Gram-negative or Gram-positive, can lead to oversecretion
of cytokines and fatal sepsis syndrome. It is now widely
accepted that the overreaction of the host occurs at the
level of the innate immune system and is directly linked to
the recognition of bacterial cell wall components, such as
lipopolysaccharide (LPS) from Gram-negative bacteria or
lipoteichoic acid (LTA) from Gram-positive bacteria. Thus
the recognition of bacterial products by the innate immune
system under certain conditions seems to be detrimental for
the host.
In the last twenty-ﬁve years, great leaps forward in our
understanding of the molecular eventsthat lead to the innate
recognition of pathogens have occurred. One of the seminal
discoveries has been the identiﬁcation of a serum protein,
lipopolysaccharide-binding protein (LBP), which binds LPS
or LTA and delivers it to its cellular targets [38]. Probably
the most important discovery has been that the main family
of receptors employed by the innate immune system are the
Toll-like receptors (TLRs).Mediators of Inﬂammation 3
As far as sepsis and bacterial recognition is concerned,
TLR4 seems to be the central sensor of Gram-negative
bacterial products [15, 39], whereas TLR2 seems to be
the key receptor in activating the immune system against
Gram-positive bacteria [23]. In addition to the involvement
of TLRs, other accessory molecules seem to be involved.
CD14 is believed to act as a transfer molecule for both
Gram-negative and Gram-positive bacteria [40, 41]. In the
case of LPS recognition, it has been further shown that a
soluble molecule, MD-2 [42], as well as activation clusters
involving several other receptors [43–45]. In the case of
LTA recognition, TLR2 seems to form receptor clusters as
well, comprising of at least CD14, TLR2, TLR6, and CD36
[46]. Thus we are moving away from the single-receptor
modelofactivation,andamorecomplexpictureisemerging.
The mechanism that leads to activation seems to involve
the careful interplay of several receptor molecules as well
as serum proteins. Therefore such a complex orchestration
of events requires a nonrandom membrane architecture
speciﬁcally geared to bring receptor molecules together and
trigger activation within the lipid bilayer and lipid rafts or
membrane microdomains seem to provide this platform.
2.3.Protein-ProteinInteractions inInnateImmunity:PRRsAre
Part of Multicomponent Sensor Apparatuses. PRRs employed
by the innate immune system have been shown to have
the ability to bind and recognise conserved products of
pathogens that are unique to the invading microorganisms
but not to the host, it is becoming increasingly apparent
that the model of a single PRR recognising foreign antigen
is an oversimpliﬁed one. With the discovery of the Toll-like
receptors as the main signal transducing molecules of the
innate immune system, an onslaught of research has shown
that PRRs are part of multicomponent sensor apparatuses.
TLRs have been shown to function as homo- or het-
erodimers and to even form functional interactions with
non-TLR molecules. Many of these interactions are highly
stable,whereas others are transient, forming dynamic associ-
ations in response to speciﬁc stimuli. Whether homotypic,
heterotypic, stable, or transient, these diﬀerent protein
combinations generate considerable functional diversity for
the innate immune system by triggering distinct signalling
cascades leading to cellular activation. There are a number
of examples that suggest that TLR associations are required
for cellular activation. TLR4 seems to form a complex with
at least two other molecules, CD14 and MD2, in order to
recognisebacterialLPS[47].Inaddition,itseemstoassociate
with a Toll-like receptor homologue RP105, which acts as a
negative regulator of TLR4 responses [48]. TLR2 has been
found to heterodimerize with TLR1 or TLR6 for recognition
of yeast components [30] and to associate with TLR1 for the
recognition of bacterial lipoproteins. In addition, TLR2 has
beenshown to also interact with scavengerreceptorsin order
torecogniselipoproteins[46]andmost recentlyitwasshown
that TLR2 associates with CXCR4, which acts as a negative
regulator of TLR2 responses [49]( F i g u r e1). Figure 1 depicts
the possible model of TLR activation, and how TLRs and
other receptors are organized in lipid rafts on the cell surface
before and after stimulation. TLR2 forms heterodimers with
TLR1 and TLR6. These heterodimers preexist and are not
induced by the ligand (Figure 1(a)). TLR2/6 heterodimers
are recruited within lipid rafts and associate with lipid raft-
resident proteins CD14 and CD36 upon ligand engagement.
Binding of appropriate microbial substances leads to energy-
dependent clustering of heterotypic receptors and activation
of intracellular signaling cascades that lead, for example,
via NF-κB to production and secretion of proinﬂammatory
cytokines (Figure 1(b)).
Functional associations of TLRs with non-TLR mole-
cules have also been demonstrated, for example, TLR2
association with dectin-1 is required for macrophage and
dendritic cell activation by β-glucan-containing particles.
More recently, functional interactions of TLR2 and CD36
have been shown to be involved in the recognition of
diacylglycerides [46]. TLR4 seems to be the best example of
TLRs associating with non-TLR molecules. As it has already
been mentioned, TLR4 has been shown to form at least
a trimolecular complex with CD14 and MD2 in order to
recognise bacterial LPS [39]. The possibility that additional
receptor components such as heat shock proteins [43, 50],
CXCR4 [43], or CD55 [45] have been suggested to be part
of this activation cluster, possibly acting as additional LPS
transfer molecules. Furthermore, it has been demonstrated
that diﬀerent “shapes” of LPS induce the formation of
diﬀerent activation clusters, involving the association of
TLR4 with a variety of molecules mentioned above, which
seems to determine LPS responses [51].
Recent structural studies have shed some light onto TLR
associations, supporting the hypothesis of cluster formation,
since all TLRs that have been crystallised have been found to
be in a dimer formation, thus the hypothesis has been put
forward that dimerisation or clustering might be a common
feature of the TLRs and might be essential for signalling.
Structural studies of TLRs have been an attractive
area of research since structural information is crucial
in understanding receptor function. In 2005, the crystal
s t r u c t u r eo fT L R 3w a st h eﬁ r s to n et ob er e v e a l e d[ 52]. It
was surprising, that although the structure did not have a
ligand, TLR3 was crystallised as a dimer. In 2007 and 2008,
three structures of TLR-ligand complexes were revealed,
TLR1-TLR2-lipoprotein, TLR4-MD-2-Eritoran, and TLR3-
dsRNA [53–55]. The ectodomains were found to form
dimers, which were strikingly similar in shape. Prior to the
publication of the crystal structures, Gayand Gangloﬀ [56]
suggested a possible model of activation, where dimerization
was ligand induced. These observations have suggested the
hypothesis that dimerization of the ectodomains forces the
intracellular TIR domains to dimerize, and this initiates
signalling by recruiting the intracellular adaptor molecules,
such as MyD88, MAL, TRIF, and TRAM in order to initiate
signalling. The structures of the TIR domains of TLR1,
TLR2, and TLR10 have been revealed [57]. Interestingly,
the TIR domain of TLR10 was shown to be involved
in a homodimeric interaction. However, it is not certain
whether the structure seen in the crystal corresponds to
a physiologically relevant dimer of TLR10 TIR domains
because they have been found to exist as monomers in
solution.Interestingly ithasbeenrecentlysuggested[58]that4 Mediators of Inﬂammation
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Figure 1: Activation of TLRs and adjuvant receptors on cell surface before and after stimulation by bacterial products. (a) TLR2 forms
heterodimers with TLR1 and TLR6 on the cell surface and these heterodimer preexist and are not induced by the ligand. These heterodimers
do not reside in lipid rafts before stimulation but are recruited to lipid rafts upon stimulation. This process is independent of signaling and
facilitates the traﬃcking of TLRs from the cell surface to the Golgi. (b) TLR2/6 heterodimers are recruited within lipid rafts and associate
with lipid raft-resident proteins CD14 and CD36 upon ligand stimulation. Binding of an appropriate microbial substance leads to energy-
dependent clustering of heterotypic receptors and activation of intracellular signaling cascades that lead via NF-κB to the production and
secretion of proinﬂammatory cytokines.
MyD88 interacts with IRAK4 in an 8:4 ratio in solution,
suggesting that maybe there is higher oligomer formation.
In order for such higher oligomers to be formed and in
order to have such a well-orchestrated accumulation of re-
ceptors and signalling machinery membrane partitioning
seems to be crucial for the formation of these “TLR multi-
component sensor apparatuses”.
2.4. TLR4 Recruitment to Membrane Microdomains upon
Ligand Engagement. TLR4wastheﬁrstonetobeshowntobe
recruited to lipid rafts upon stimulation by bacterial LPS [7].
Within these membrane microdomains it was shown that
TLR4 formed clusters with non-TLR molecules that tailored
the immune response against the particular pathogen [43,
59–62].
Itwassubsequentlyshownthatthisaccumulationinlipid
rafts also inﬂuenced its internalization and targeting. TLR4
was found to accumulate in lipid rafts, to internalize in a
lipid-raft-dependent manner and to be targeted to the Golgi
apparatus [63]. This intracellular targeting was shown to be
independentofsignalling, thussuggesting thataccumulation
in lipidraftsonlyfacilitatedligand recognitionandsignalling
that was initiated at the cell surface and not in the intracellu-
lar compartments where TLR4 was targeted to [63].
More recently it had been proposed that the molecular
mechanism for signalling by the TLRs must involve a series
of protein conformational changes initiated by dimerization
of their extracellular domains [64]. It was suggested that this
receptor-receptor association of the extracellular domains
forced the association of the cytoplasmic domains as well.
Motshwene et al. [58] recently proved this experimentally,
demonstrating that the death domains of human MyD88,
one of the adaptor proteins used by all but one of the
TLRs, and IRAK4 assemble into closed complexes with
stoichiometries of 7:4 and 8:4, which they called the Myd-
dosome. The ability to form 7:4 or even8:4 stoichiometries
suggestsamechanism bywhichclustersofactivated receptors
concentrate in lipid rafts and their intracellular machineryMediators of Inﬂammation 5
clusters as well, forming a signalling platform that seems to
be crucial for TLR activation.
2.5. Does Membrane Partitioning Play a Major Role in Protein
Uptake and Intracellular Routing? Cell membranes display
a tremendous complexity of lipid and proteins designed
to perform the functions cells require. To coordinate these
functions, the membrane is able to laterally segregate its
constituents.Lipidraftswereoriginallyproposedasanexpla-
nation for a nonrandom membrane architecture and their
function was originally thought to be linked with membrane
traﬃcking. However, rafts proved to be able to inﬂuence
organization of membrane receptors and bioactivity as well
as membrane traﬃcking.
It is now emerging that this membrane partitioning
might play a major role in protein uptake and intracellular
routing. It is becoming more apparent that this diﬀerential
sorting on the cell surface might pre-dispose the intra-
cellular fate of a given molecule. Since the discovery of
clathrin-coated pits by Roth and Porter in 1964 [65], as
specialised sites for the selective recruitment of specialised
moleculesthatareinternalised intoeukaryoticcells,clathrin-
independent endocytic pathways have now emerged. Endo-
cytic pathways that do not rely on the formation of clathrin
coated pits include the earliest identiﬁed pathways such
as phagocytosis, macropinosis, and caveolae. Lipid rafts
might involved in all of these pathways. In particular for
phagocytosis, it has been shown that lipid rafts play a
crucial role in the phagocytic uptake of latex microspheres
[66], suggesting that these specialised microdomains on
the plasma membrane are necessary for endocytosis and
phagocytosis.
Furthermore, caveolae which is deﬁned as small, un-
coated invaginations in the plasma membrane containing
the plasma protein caveolin 1 has been shown to be
able to bind cholesterol and to be resistant to detergent
extraction [67], and this has led to the suggestion that
caveolae might constitute a type of lipid raft [68]. Lipid rafts
are increasingly becoming linked with clathrin-independent
endocytosis, since nearly all molecules that are known
to be internalised independently of clathrin are found in
biochemically deﬁned rafts [69]. It has been suggested that
raftcomponentsmightbetakenuppreferentiallybyclathrin-
independent endocytosis. There are likely to be several types
of clathrin-independent endocytosis. The extent to which
these diﬀerent pathways require lipid rafts to operate or are
somehow selective for lipid rafts is currently the subject of
intensiveinvestigation.Recently,Nicholsetal.havedescribed
a rapid lipid-raft-dependent targeting from the cell surface
to the Golgi apparatus [70]. In addition, a new clathrin-
independent mechanism has been described that can lead to
delivery of receptor molecules from the plasma membrane
to caveolin-1-containing endosomes, termed “caveosomes”
[71]. With the emergence of these new clathrin-independent
uptakemechanisms theideathatdiﬀerenttypesofendocyto-
sis have markedly diﬀerent functions is beginning to become
apparent. Ultimately we have to speculate that sorting at the
plasma membrane might predispose the intracellular route
that a molecule might take. If that is the case, then where are
theraft-associated molecules,such as TLR4,targetedto? And
most importantly why?
This intracellular targeting seems to be independent of
signalling. TLR2 has also been found to reside in lipid rafts
after stimulation by Gram-positive bacterial products and to
be similarly targeted to the Golgi apparatus [72]( F i g u r e1).
The question that remains is whether lipid raft association is
common for all TLRs expressed at the cell surface? If this is
the case, do they all follow the same intracellular route? Do
diﬀerent signalling cascades require diﬀerential targeting of
TLRs and their ligands?
InthecaseoftheER-resident TLRs,very littleevidenceof
their traﬃcking upon stimulation exists. To date only TLR9
has been found to translocate from the ER to lysosomes in
response to its ligand, CpG DNA [73]. Based on the ﬁndings
forTLR9,ahypothesishasbeenputforward thatER-resident
TLRs might become accessible to endosomal and lysosomal
compartmentsaftertheERfuseswithsitesofmicrobialentry.
If this is the case, then it would seem that ER membrane
fusion might be critical for microbial recognition by ER-
resident TLRs.
2.6. Do Lipid Rafts Control Endosomal Innate Immune Dy-
namics? The regulation of endosome dynamics is crucial
for fundamental cellular functions, such as nutrient in
take/digestion, membrane receptor recycling/degradation,
antigen presentation, cell migration, and intracellular signal-
ing [74–76]. The system is also utilised by various pathogens
to bud in and from the cell [77].
In addition to the function asad i s t r i b u t i o nc e n t r e ,i t
has been proposed that the endosome system serves as an
intracellular signalling station [78]. In the case of innate
immunity this is certainly the case, since TLR3, TLR7, TLR8,
and TLR9 all reside within the endosome waiting to capture
incoming PAMPs and trigger signalling. Endosomes are
pleiomorphic organelles composed of tubular elements as
well as vesicular regions with a characteristic multivesicular
appearance.Thequestionthatremainsiswhetherinaddition
to these morphologically distinguishable regions, endosomal
membranes are further subcompartmentalized into mem-
brane lipid rafts or microdomains.
Lipid rafts have mostly been studied at the plasma
membrane, mainly due to accessibility for microscopy and
biophysical methods [79]. Characterisation of lipid rafts has
also been extensively based on their resistance to detergent
solubilisation, although this has inherent limitations [80],
as well as ﬂuorescent microscopy [79]. Although most
studies have focused on the existence of lipid rafts on plasma
membranes, many intracellular organelles appear to contain
raft-likedomains[81–84].Duetoitslowcholesterol content,
the endoplasmic reticulum was originally thought not to
contain cholesterol-dependent microdomains. However,
recentlyseveralstudieshavereported theirexistence [85, 86].
Raft-like domains have been described in the Golgi and
trans-Golgi network [87, 88], along the endocytic pathway
[84]a sw e l la si nt h ee n d o s o m e s[ 89–91]. Althoughpotential
roles oflipidrafts fortheoutermembrane havebeendemon-
strated, including endocytosis, exocytosis, vesicle formation,
and signalling, the functions of lipid rafts in the processes of6 Mediators of Inﬂammation
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Figure 2: Activation ofTLRs in endosomes.VariousTLRs recognize microbialpatterns withinthe endosome.TLR7 and 8 recognize ssRNA,
whereas TLR9 recognises CpG DNA. As nucleic acid recognition bears a potential source for the induction of autoimmunity, TLR7 and 9
exist in a full-length and truncated version, where the ectodomain is cleaved. Only the endosomally processed forms are capable to recruit
MyD88andtoinduce signaling.Transportfromtheendoplasmaticreticulum (ER)isfacilitatedbyUNC93B1(a).LigationofTLR7byssRNA
leads to clustering within a lipid raft at the endosomal membrane and activation of intracellular signaling cascades that lead via NF-κBt o
production and secretion of proinﬂammatory cytokines (b).
endosomal membrane dynamics are currently unknown.
We can only speculate that they are contributing to similar
functions. It has been suggested that protein and lipid
sorting into and out of the endosomes may be controlled
by endosomal membrane partitioning [89], but whether
these microdomains control signalling and in particular
TLR signalling has not been investigated. Since most
extracellular TLRs have been shown to be recruited to
lipid rafts upon ligand activation, it is safe to assume that
endosomal TLRs act in a similar manner, especially since
the existence of cholesterol-dependent microdomains on
the endosomal membranes has been proven (Figure 2).
Thus it is safe to assume that membrane partitioning
control both extracellular and intracellular TLR-dependent
signalling. We are proposing a model for endosomal TLR
activation, where ligation of endosomal TLRs by their
respective ligands can lead to clustering within lipid rafts
at the endosomal membrane and activation of intracellular
signaling cascades that lead via NF-κB to production and
secretion of proinﬂammatory cytokines (Figure 2(b)).
2.7. Existence of Other PPRs in Lipid Rafts. C-type lectin
receptors (CLRs), such as Dectin 1, are a family of pattern
recognition receptors which bind β-glucan found in the cell
wallsofpathogenicfungisuchasCandida albicans .I npartic-
ular Dectin 1 has been shown to mediate the phagocytosis of
yeast and yeast-derived particles, such as zymosan, activating
the production of inﬂammatory cytokines [92–94]. Inter-
estingly, Dectin-1 possesses an immunotyrosine-activated
motif (ITAM) in its cytoplasmic tail, suggesting that it is
capable of mediating signalling analogous to the BCR and
TCR.Sinceboth theBCRand TCRhavebeenfound toreside
in lipid rafts it was suggested that Dectin-1 might also be
recruited there upon activation. A recent study has revealed
that Dectin-1 and possibly other CLRs are recruited to lipid
rafts upon activation and raft integrity is important forMediators of Inﬂammation 7
signalling [95]. Thus suggesting that recruitment to lipid
rafts is a common feature for most PRRs, including TLRs
and CLRs.
2.8. Concluding Remarks. Cell membranes are complicated
in composition but precise in purpose: to selectively com-
partmentalize its constituents in order to coordinate cellular
functions. In this way, the membrane is able to compart-
mentalize, segregate receptors as well as their signalling
machinery and create oligomeric signalling platforms in
order to transduce signals. Once the required function has
subsided, these segregated islands are involved in internal-
ization and membrane traﬃcking, thus bringing the whole
function to a close. The innate and acquired immune
systems seem to utilise this membrane partitioning for
their functions. In this paper, we have extensively looked
at the use of this membrane partitioning by the innate
immune system and most particular by the TLRs. The
molecular mechanism involved in LPS recognition and TLR
signalling in general, utilises a series of protein lipid as
well as protein-protein interactions. The plasma membrane
seems to be heterogeneous and to coalesce to more stable
membrane-ordered assemblies upon activation by ligands.
This partitioning of the membrane and the assembly of
more stable raft platforms in the functionalized state must
be initiated by raft-resident proteins, which form protein-
lipid as well as protein-protein interactions. The TLRs and
other PRRs associate with the raft-resident proteins and
are recruited to these “ﬂoating islands” forming higher
oligomers, both extracellularly as well as inside the cell,
concentrating their signalling machinery which ﬁnally leads
to a functional, focused, and coordinated activation of the
innate immune system.
The lifetime of these domains and the length of the
response will depend on their size and factors that may sta-
bilise or destabilise them. These factors will include not only
lipid-lipid, lipid-protein and protein-protein interactions
both in the plane of the membrane but also elements of the
cytoskeleton, pericellular matrix adjacent to the membrane
as well as transmembrane and cytoplasmic domains of the
r e c e p t o r si n v o l v e d .I nt h ec a s eo fT L R s ,t h ea s s o c i a t i o no ft h e
TIR domains intracellularly would stabilise the ectodomains
extracellularly and provide the molecular scaﬀold that will
recruit the adaptor molecules that contribute to signalling.
The challenge for the future will be to visualise the assembly
and stoichiometry of these large and transient oligomeric
complexes in vivo. Thus reﬁning existing biophysical meth-
ods, such as single particle tracking (SPT), ﬂuorescence
correlation spectroscopy (FCS), and ﬂuorescence resonance
energy transfer (FRET) will help us reveal these dynamic
nanoassemblies of sterol, sphingolipid, and proteins in living
cell and provide us with the ﬁrst dynamic picture of the
innate immune response.
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